Redwood AI Touts Ebola Surveillance Deal as Shares Sink and Board Member Quits

Redwood AI Corp. proposes AI-driven Ebola surveillance in Congo-Rwanda outbreak, but stock plunges 26% as cash dwindles and board member resigns.

As the Democratic Republic of Congo and Rwanda grapple with a Bundibugyo Ebola outbreak that has already claimed 136 lives and infected 676 people, Redwood AI Corp. has stepped forward with a plan to deploy artificial intelligence for real-time pathogen tracking. But investors, focused on the company’s dwindling cash reserves and a sudden board resignation, have greeted the initiative with a resounding sell-off.

The Vancouver-based firm signed a non-binding letter of intent on June 11, 2026 with Dr. Placide Sesonga of the University of Global Health Equity in Rwanda to develop an AI-driven early-warning system for disease outbreaks along the border between Rwanda and the Democratic Republic of Congo. The proposed system would combine pathogen surveillance, metagenomic sequencing and geospatial analysis with Redwood AI’s own forecasting platform, targeting border crossings, transit hubs and urban centers where zoonotic spillover risks are highest.

Health authorities have confirmed the outbreak, which began in Ituri province, has now spread to 27 health zones, while the World Health Organization has warned of blind spots in monitoring caused by conflict and misinformation. Redwood AI’s technology aims to fill those gaps by comparing data from previous outbreaks and identifying case locations.

Yet the market remains unimpressed. After Friday’s 7.5% slide, the stock closed at 2.95 Canadian dollars, bringing its weekly loss to nearly 26% and extending its year-to-date decline to roughly 18%. The company’s financial position explains much of the skepticism: Redwood AI holds just 2 million CAD in cash against an 11 million CAD deficit — a gap that leaves little room for execution risk on any of its multiple ventures.

Adding to the unease, board member Graydon Bensler resigned with immediate effect. The company offered no explanation for his departure and has not named a successor.

Redwood AI is pursuing an ambitious multi-front strategy beyond disease surveillance, positioning its platform at the intersection of defense, public safety and post-quantum cryptography. In Canada it works with law enforcement agencies on British Columbia’s “Track and Trace” program and the National Research Council’s hazardous-materials project “Q-SAFE.” A planned acquisition of Quantum.IQ, intended to bolster quantum security capabilities, also remains at the non-binding-letter stage since May 2026, with no definitive agreement in sight.

The Rwanda project now becomes a critical test. If the company can prove its technology works in an active health crisis, it may unlock government contracts that could shore up its precarious finances. If not, Redwood AI risks remaining what it currently looks like to many shareholders: a micro-cap with grand ambitions, a vanishing board member, and more letters of intent than tangible contracts.